Acute Effect of Lemborexant on CSF Amyloid-Beta and Tau

NCT05728736 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped Study was terminated due to enrollment difficulties and the inability to obtain necessary study supplies. Five participants signed consent; however, no one was randomized. The study was officially terminated with the funding source on 10/04/2023.

Conditions

Interventions

Sponsor

Brendan Lucey

Collaborators